Model‐Informed Drug Development Approach to Expedite Approval: Case of Alectinib in First‐Line Anaplastic Lymphoma Kinase + Non‐Small Cell Lung Cancer
2019 ◽
Vol 40
(2)
◽
pp. 183-189
◽
Keyword(s):
2018 ◽
Vol 13
(10)
◽
pp. S584
◽
Keyword(s):